Agilent Technologies and Transcriptic have partnered their technologies in an effort to provide a solution for convenient, broad scale synthetic and discovery biology research. Agilent uses its portfolio by collaborating with companies such as Transcriptic to develop novel synthetic biology solutions. Transcriptic’s automated discovery biology platform enables scalable life science research through a convenient and simple web interface. Biologists who use the platform can control their scien...